Astrada

Name: Astrada
Brand: Astrada

AI Native

The unified API for real-time transaction feeds

Est 2024|Raised $3.8M|4 Ref Customers

LinkedIn 1K|Website|FTEs 43|HQ San Francisco, CA

Published Sep 26, 2026

01Common complaints

- When you require publicly documented SOC 2 / ISO 27001 certifications - Astrada does not publish these certifications in accessible pages; regulated enterprises may prefer vendors with clearly published compliance. - When you need abundant independent third-party reviews and benchmark comparisons - Astrada has limited visibility on mainstream review platforms in accessible results. - When integration correctness is the single highest risk and you cannot tolerate manual validation work - Regional audit commentary indicates that mismatches in transferred data (codes/diagnoses) can create ongoing administrative overhead if upstream systems are inconsistent. - When you require a broad, global connected-planning standard platform across many departments - Platforms such as Anaplan, Workday Adaptive, or Tagetik may be better fits for enterprise-wide standardization supported by large ecosystems. - Limited public transparency on security posture - No public SOC 2/ISO attestations were found; documentation on encryption, SSO, audit logs, and data residency is limited. - Integration/data correctness can be a practical challenge - A regional audit report documents data transfer inconsistencies from upstream healthcare systems into Astrada, requiring manual correction/validation. - Limited public third-party review footprint - Absence on major review platforms makes independent validation of vendor claims more difficult for buyers. - Roadmap visibility - The vendor does not publish a detailed public roadmap with dates on astrada.se.

Deal disqualifiers: what makes a POOR fit

Requirement for out-of-the-box self-serve SaaS with published pricing and minimal implementation
Environments with poor upstream data quality where stakeholders are unwilling to fund cleanup
Requirements for specific security attestations (e.g., SOC 2 Type II) if the vendor cannot provide them

02Why they buy

- Long operational history in the domain (founded 2002) - Astrada has been operating in costing/profitability and planning support since 2002. - Evidence of deployments in Swedish healthcare regional contexts - Event listings and public documents indicate use in healthcare contexts within Sweden. - Scheduling optimization designed to incorporate local constraints - The scheduling capability is presented with constraint handling for legislation and agreements; buyers should validate specifics and limitations. - Areas where competitors may have advantages - Enterprise compliance transparency (SOC2/ISO), larger partner ecosystems, and broader product roadmaps are typically stronger among large CPM/EPM vendors.

03Field reports

Important context about review availability

Major review platforms (G2, TrustRadius, Capterra, PeerSpot) did not show accessible product review pages for Astrada during this research.
As a result, this section relies largely on vendor-published testimonials on the vendor website and on public-sector / third-party documents referencing Astrada usage and issues.

Vendor-published testimonials (marketing-controlled)

The vendor site includes anonymized or briefly attributed customer comments that emphasize improved visibility into profitability, improved internal communication, and improved data handling relative to prior approaches. These are vendor-published statements and do not include baseline measurements or independent verification.

Third-party/audit-style feedback (more critical)

A third-party audit report for Region Jönköpings län (dated 2024-10-29) describes generally positive work around production and capacity planning but also documents issues with data transfer correctness from upstream systems (Diver and Cosmic) into Astrada, which required manual corrections and administrative validation by clinics.

Inferred reasons for customer selection

Customers appear to select Astrada when they require:
- Multi-dimensional profitability/cost allocation modeling with traceability
- Healthcare production/capacity planning support aligned to regional operating models
- Scheduling optimization that accounts for multiple constraints (including legislative and agreement-based rules)

Potential churn drivers (inferred)

No direct churn narratives were found in public sources. However, audit references to integration/data correctness issues suggest a plausible dissatisfaction vector when manual validation and reconciliation remain necessary after implementation.

Vendor case studies

The vendor site provides testimonials and high-level claims but limited detailed case studies with fully named customers, baselines, and quantified ROI.
Vendor-reported scale metrics (e.g., user counts, clinic deployments, allocation/value figures) are presented without methodology disclosure.

Public-sector adoption evidence (informative)

An exhibitor listing from a healthcare event describes Astrada’s healthcare portfolio and indicates usage in some Swedish regions; this signals presence in the healthcare event ecosystem but does not provide independent usage metrics.
A survey page from the Swedish Association of Local Authorities and Regions (SKR) lists Astrada among tools reported by some respondents for KPP/KPS systems.

Critical evaluation

Areas with relatively stronger supporting evidence:
- Use in Swedish regional healthcare operational contexts (KPS/KPP)
- Long operational history and sustained presence in specialized decision-support domains
Areas with weaker public evidence:
- Independently verifiable ROI metrics and third-party case studies with controlled measurement

04Best fit

Company sizes

Likely mid-market to enterprise:
- Public-sector regions / large healthcare organizations
- Industrial firms with complex product/customer/channel profitability needs
Third-party listings suggest Astrada is a small vendor (vendor headcount listed as small); this describes vendor size, not customer size.

Industries and verticals where adoption is strongest

Healthcare (regional public healthcare organizations; clinics)
Manufacturing and process industries (examples cited on vendor materials)
Logistics/transport, finance, and trade/retail (listed in vendor materials as current industries)

Roles and personas: decision makers AND end users

Decision makers: CFO / finance leadership; COO / operations leadership; regional healthcare operations leaders; CIO / IT leadership
End users: Controllers / FP&A; operational planners / schedulers; clinic managers and planning teams; analysts using dashboards or exports

Pain points and challenges the product addresses

Need for traceable, multi-dimensional cost allocation and profitability views
Desire to maintain allocation logic over time (versus intermittent consulting engagements)
Planning and capacity balancing challenges in healthcare operations
Scheduling constraints involving legislation and labor agreements

Qualification criteria: what makes a GOOD fit

High cost complexity with need for allocation transparency
Commitment to data governance and code/diagnosis standardization in healthcare contexts
Willingness to invest in integration and ongoing model stewardship

05The pitch

What the product does (core value proposition in objective terms)

- Astrada (Astrada AB, Sweden) develops and delivers data-driven decision-support applications focused on: - Costing & profitability analysis (including activity-based costing style allocations) - Planning & scheduling (including healthcare production/capacity steering and schedule optimization) - RFQ/offering & pricing support - Sustainability calculations (product-specific carbon footprint) - The company offers software intended as a decision-support and business intelligence platform where customers can retain and update models over time (rather than one-off consulting analyses) and use outputs for operational decisions and longer-term planning.

Target market and market positioning

Mid-market to enterprise organizations (Astrada references large industrial customers historically; public sector/healthcare usage appears significant in Sweden).
Emphasis on Swedish healthcare regions for production/capacity steering (PKS/KPS) and scheduling, alongside industrial profitability/cost allocations.

Get a comprehensive analysis of Astrada including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →